Osiris Therapeutics, Inc. (NASDAQ:OSIR) Shareholder Alert: Lawsuit Alleges False and Misleading Statements
A shareholder of Osiris Therapeutics, Inc. filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Securities Laws by Osiris Therapeutics, Inc. in connection with certain allegedly false and misleading statements.
View full press release